6560 - Medical Treatments (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, how NHS England's evaluation through commissioning programme will align with the Accelerated Access Review and the test bed programme outlined in the NHS five year forward review.

George Freeman

7744 - Medical Records: Risk Management (Answered)

Mr Jamie Reed
To ask the Secretary of State for Health, what assessment he has made of the implications for his policy of the red risk rating of the care.data programme by the Major Projects Authority.

George Freeman

The ‘red rating’ relates to a review of the programme carried out by the Major Projects Authority in May 2014. A subsequent review undertaken in February of this year reported the care.data programme as Amber/Red reflecting the progress made.

7308 - Cancer: Drugs (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, what progress NHS England's Short Life Working Group on reform of the Cancer Drugs Fund has made; and when he expects that Group to report.

George Freeman

NHS England’s Cancer Drugs Fund Working Party was established to inform NHS England’s deliberations on the development of proposals for the future evaluation and commissioning of cancer drugs.

NHS England has advised that the outputs from these deliberations will inform a discussion at the July meeting of the NHS England Board.

7310 - Cancer: Drugs (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, whether his Department will submit a response to NHS England's consultation on the Cancer Drugs Fund Standard Operating Procedures; and if he will make a statement.

George Freeman

7309 - Cancer: Drugs (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, how many cancer treatments have been (a) denied entry to or (b) removed from the Cancer Drugs Fund on cost grounds since January 2015.

George Freeman

NHS England has advised that no cancer treatments have been removed from or denied entry to the Cancer Drugs Fund (CDF) on cost grounds alone. NHS England’s CDF panel makes its prioritisation decisions based on the national CDF prioritisation tool.

7364 - Cancer: Drugs (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, what plans NHS England has to remove treatments included on the National Cancer Drugs Fund list; and what estimate his Department has made of the number of treatments on the National Cancer Drugs Fund list that are likely to be removed in prioritisation reviews in the next five years.

George Freeman

NHS England has advised that its Cancer Drugs Fund (CDF) panel expects to hold a meeting on 29-30 July 2015 to prioritise the drugs/indications currently available on the national CDF list.

7010 - Department for Business, Innovation and Skills: Tobacco (Answered)

Owen Smith
To ask the Secretary of State for Business, Innovation and Skills, how many times (a) he and (b) other Ministers in his Department met employees or third-party representatives of tobacco companies in (i) 2013, (ii) 2014 and (iii) 2015.

George Freeman

Details of Ministers’ meetings with external organisations are published quarterly on the Gov.uk website:

7038 - Cancer: Drugs (Answered)

Angela Rayner
To ask the Secretary of State for Health, whether doctors will be able to make applications for cancer drugs for their patients from the Cancer Drugs Fund after May 2016.

George Freeman

Since it was established, the Cancer Drugs Fund has helped over 72,000 people in England to receive the life-extending cancer drugs that would not otherwise have been routinely available to them.

This Government has committed to continuing to invest in the Fund.

6644 - Skin Cancer: Medical Treatments (Answered)

Carolyn Harris
To ask the Secretary of State for Health, what discussions his Department has had on the availability of new treatments for (a) skin cancer patients and (b) patients with advanced melanoma.

George Freeman

A number of drugs for the treatment of skin cancers including melanoma are licensed and are available for use on the National Health Service, subject to funding decisions by the relevant commissioner.

6352 - Levodopa: Gambling (Answered)

Jim Shannon
To ask the Secretary of State for Health, what recent discussions he has had with clinical and medical bodies on potential links between use of levodopa and gambling problems.

George Freeman

There have not been any recent discussions with clinical and medical bodies regarding the potential link between the use of levodopa and gambling problems. Gambling problems are recognised to be a risk associated with levodopa and dopamine agonists used to treat Parkinson’s disease.

Pages